SCHEMBL29919280

SCHEMBL29919280

CNC(=O)c1cc(B(O)O)ccc1F

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.53
NUDT1 P36639 2/20 0.41
ALDH1A1 P00352 1/20 0.37
PADI4 Q9UM07 1/20 0.37
MAP2K1 Q02750 2/20 0.36
MAP2K2 P36507 1/20 0.36
CES2 O00748 1/20 0.36
CES1 P23141 1/20 0.36
PSMB11 A5LHX3 1/20 0.36
PSMA7 O14818 1/20 0.36
PSMB1 P20618 1/20 0.36
PSMA1 P25786 1/20 0.36
PSMA2 P25787 1/20 0.36
PSMA3 P25788 1/20 0.36
PSMA4 P25789 1/20 0.36
PSMB8 P28062 1/20 0.36
PSMB9 P28065 1/20 0.36
PSMA5 P28066 1/20 0.36
PSMB4 P28070 1/20 0.36
PSMB6 P28072 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3326392 1.00 GAA (0.53) GAANUDT1ALDH1A1PADI4MAP2K1
SCHEMBL245377 0.86 GAA (0.53) GAANUDT1ALDH1A1MAP2K1MAP2K2
SCHEMBL29954131 0.82 LMNA (0.42) GAAPADI4PSMB11PSMA7PSMB1
SCHEMBL4063989 0.82 ALOX5 (0.42) GAAALDH1A1PADI4PSMB11PSMA7
SCHEMBL14484567 0.82 POLB (0.50) PSMB8PSMB5
SCHEMBL29952959 0.82 ALOX5 (0.42) GAAALDH1A1PADI4PSMB11PSMA7
SCHEMBL29952155 0.82 MAP2K1 (0.40) GAAALDH1A1PADI4MAP2K1PSMB11
SCHEMBL4847318 0.80 CES2 (0.39) CES2CES1
SCHEMBL29953221 0.80 L3MBTL1 (0.49) GAAALDH1A1PADI4PSMB11PSMA7
SCHEMBL237491 0.79 ALDH1A1 (0.43) GAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4087843-A1 TRICYCLIC COMPOUNDS AS INHIBITORS OF KRAS Incyte Corporation (US) 2022-11-16 EP disclosed
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed
WO-2022216655-A1 N-(6-((OCTAHYDROCYCLOPENTA[C]PYRROL-5-YI)AMINO)PYRIDAZIN-3-YL)PHENYL)CARBOXAMIDE AND (6- ((OCTAHYDROCYCLOPENTA[C]PYRROL-5-YL)AMINO)PYRIDAZIN-3-YL)BENZAMIDE DERIVATIVES AS MACHR M4 ANTAGONISTS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS VANDERBILT UNIVERSITY (US) 2022-10-13 WO disclosed